These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 16193311

  • 21. Dual-time-point [18F]-FDG PET/CT in the diagnostic evaluation of suspicious breast lesions.
    Caprio MG, Cangiano A, Imbriaco M, Soscia F, Di Martino G, Farina A, Avitabile G, Pace L, Forestieri P, Salvatore M.
    Radiol Med; 2010 Mar; 115(2):215-24. PubMed ID: 20017002
    [Abstract] [Full Text] [Related]

  • 22. Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions.
    Ciftci E, Turgut B, Cakmakcilar A, Erturk SA.
    Nucl Med Commun; 2017 Sep; 38(9):788-794. PubMed ID: 28692494
    [Abstract] [Full Text] [Related]

  • 23. 18F-FDG PET of common enhancing malignant brain tumors.
    Kosaka N, Tsuchida T, Uematsu H, Kimura H, Okazawa H, Itoh H.
    AJR Am J Roentgenol; 2008 Jun; 190(6):W365-9. PubMed ID: 18492879
    [Abstract] [Full Text] [Related]

  • 24. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
    Delbeke D, Rose DM, Chapman WC, Pinson CW, Wright JK, Beauchamp RD, Shyr Y, Leach SD.
    J Nucl Med; 1999 Nov; 40(11):1784-91. PubMed ID: 10565771
    [Abstract] [Full Text] [Related]

  • 25. Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions.
    Xu R, Kido S, Suga K, Hirano Y, Tachibana R, Muramatsu K, Chagawa K, Tanaka S.
    Ann Nucl Med; 2014 Nov; 28(9):926-35. PubMed ID: 25107363
    [Abstract] [Full Text] [Related]

  • 26. Total lesion glycolysis as the best 18F-FDG PET/CT parameter in differentiating intermediate-high risk adrenal incidentaloma.
    Kim YI, Cheon GJ, Paeng JC, Cho JY, Kang KW, Chung JK, Kim EE, Lee DS.
    Nucl Med Commun; 2014 Jun; 35(6):606-12. PubMed ID: 24598843
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Evaluation of contrast medium enhancement and [(18)F]-FDG uptake of liver metastasis in PET/CT prior to therapy.
    Hundt W, la Fougère C, Vogtmann J, Steinbach S, Burbelko M, Tiling R.
    Eur J Radiol; 2012 Apr; 81(4):652-7. PubMed ID: 21300504
    [Abstract] [Full Text] [Related]

  • 29. Comparison of MR imaging and FDG-PET/CT in the differential diagnosis of benign and malignant vertebral compression fractures.
    Cho WI, Chang UK.
    J Neurosurg Spine; 2011 Feb; 14(2):177-83. PubMed ID: 21214309
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF, Liu Y, Zhang JH, Zhou RS, Zhou FH, Yuan MH.
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [Abstract] [Full Text] [Related]

  • 33. The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.
    Shin DS, Shon OJ, Han DS, Choi JH, Chun KA, Cho IH.
    Ann Nucl Med; 2008 Aug; 22(7):603-9. PubMed ID: 18756363
    [Abstract] [Full Text] [Related]

  • 34. Utility of PET/CT in differentiating benign from malignant adrenal nodules in patients with cancer.
    Vikram R, Yeung HD, Macapinlac HA, Iyer RB.
    AJR Am J Roentgenol; 2008 Nov; 191(5):1545-51. PubMed ID: 18941099
    [Abstract] [Full Text] [Related]

  • 35. F-18 FDG PET/CT in the management of thyroid cancer.
    Iagaru A, Kalinyak JE, McDougall IR.
    Clin Nucl Med; 2007 Sep; 32(9):690-5. PubMed ID: 17710020
    [Abstract] [Full Text] [Related]

  • 36. Dual-time-point 18F-FDG PET/CT versus dynamic breast MRI of suspicious breast lesions.
    Imbriaco M, Caprio MG, Limite G, Pace L, De Falco T, Capuano E, Salvatore M.
    AJR Am J Roentgenol; 2008 Nov; 191(5):1323-30. PubMed ID: 18941064
    [Abstract] [Full Text] [Related]

  • 37. Diagnostic value of positron-emission tomography textural indices for malignancy of 18F-fluorodeoxyglucose-avid adrenal lesions.
    Thuillier P, Bourhis D, Schick U, Alavi Z, Guezennec C, Robin P, Kerlan V, Salaun PY, Abgral R.
    Q J Nucl Med Mol Imaging; 2021 Mar; 65(1):79-87. PubMed ID: 30916534
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.